FDA's denial of the two remaining sunscreen time-and-extent applications, including one for an ingredient available OTC through a new drug application process, signals “nothing's going to get to market” anytime soon through monograph changes, says an advisor for an advocacy group.
The agency, meanwhile, says legislation Congress passed in 2014 to facilitate making more sunscreen ingredients available did not lower the threshold for adding ingredients to
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?